NCT07127055Completed
Gluten Free Diet on Metabolic Syndrome
Modulation of Metabolic Parameters Among Obese Diabetic Individuals Through a Gluten-Free Diet
Source: ClinicalTrials.gov · Last updated 17 Aug 2025
Brief summary (registry, in English)
This study benefits the community by highlighting the potential of a gluten-free diet as a non-pharmacological, effective approach to managing obesity and type 2 diabetes. By demonstrating significant improvements in weight, blood sugar, lipid levels, and liver function, it supports dietary modification as a practical approach to enhancing metabolic health. The findings can inform public health initiatives, raise community awareness about the role of nutrition in disease management, and promote personalized dietary interventions, ultimately contributing to better prevention and control of chronic metabolic conditions.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 108 (actual)
- First submitted
- 8 Aug 2025
- Start date
- 10 Jan 2025
- Primary completion date
- 10 Apr 2025
- Lead sponsor
- University of Lahore
- Diseases
- Obesity
- NCT number
- NCT07127055
What you commit to
- Study type: Interventional
- Participants enrolled: 108
- From 10 Jan 2025 to the primary completion date, 10 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with a diagnosis of celiac disease,
- irritable bowel syndrome,
- some cancers,
- genetic illnesses,
- respiratory illnesses, and psychiatric illnesses
Who the study is looking for
- Patients who were obese diabetic adults of both genders, aged 30 to 55 years,
- body mass index (BMI) \> 25 kg/m²,
- fasting glucose level \> 135 mg/dL,
- elevated parameters of lipid profile,
- blood pressure \> 135/85 mmHg,
- Insulin Resistance (HOMA-IR) \> 2.57
Age in the registry: 30 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sana Noreen Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
Related publications
- Modulation of metabolic parameters among obese diabetic individuals through a gluten-free diet.BMC Nutr · 2026 · PMID 42010674
This page is information, not medical advice. Discuss any trial with your doctor.